Colin B. Begg is a Scottish biostatistician and epidemiologist. He is an attending biostatistician at the Memorial Sloan-Kettering Cancer Center in New York City.[1] He serves as editor-in-chief of the journal Clinical Trials.[2] He has conducted research on the role of BRCA genetic variants in the development of breast cancer,[3][4] as well as racial disparities in cancer survival rates in the United States.[5]
Colin B. Begg | |
|---|---|
| Nationality | Scottish |
| Alma mater | University of Glasgow |
| Scientific career | |
| Fields | Biostatistics, epidemiology |
| Institutions | Memorial Sloan-Kettering Cancer Center |
| Thesis | Statistical diagnosis (1976) |
| Doctoral advisor | John Aitchison |
Begg was named a Fellow of the American Statistical Association in 1996.[6]
References
edit- ^ "Colin Begg". Memorial Sloan Kettering Cancer Center. Retrieved 2018-12-07.
- ^ "Clinical Trials". SAGE Journals. Retrieved 2018-12-07.
- ^ "Breast cancer genes don't have to mean cancer". New Scientist. 2008-01-09. Retrieved 2018-12-07.
- ^ Alpert, Bill (2002-10-21). "Scary Statistics". Barron's. Retrieved 2018-12-07.
- ^ "Racial Gap in Cancer Survival Is Not Biological, Study Finds". The New York Times. Reuters. 2002-04-24. ISSN 0362-4331. Retrieved 2018-12-07.
- ^ "ASA Fellows list". American Statistical Association. Retrieved 2021-11-03.